As LINC00173 dysregulation has been documented in different types of cancer, and based on the fact that it has not been previously investigated in ALL, we evaluated its expression in two independent cohorts of BCP-ALL pediatric patients, one consisting of Mexican children and one RNA-seq data retrieved from TARGET Phase II (phs000464) repository. Here, LINC00173 is linked to cancer.